HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Senate Appropriations

This article was originally published in The Rose Sheet

Executive Summary

Senate Appropriations: Committee passes FDA budget with no changes July 17 by a 28-0 vote. In the bill, Center for Food Safety and Applied Nutrition funding increased to $94.5 mil. in FY 1998 due to a $12 mil. allocation for food safety initiatives. Excluding the increase for food initiatives, CFSAN funding was flat at $82.5 mil., compared to $83.2 mil. in fiscal 1997. Overall, FDA was budgeted $949.1 mil. for FY 1998, $5.1 mil. more than the House Appropriations Committee granted to the agency. A sum of $844 mil. was allocated to FDA salaries and expenses, a $24 mil. increase from 1997, and $93 mil. more than the White House budget request. The committee also recommended fee collections of $91.2 mil. from the Prescription Drug User Fee Act. Senate consideration of the bill is scheduled to take place as early as July 22...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel